Antimicrobial peptide clears bacteria from tumors to enhance gemcitabine therapy for pancreatic cancer
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Pancreatic and Hepatic Oncology Research · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. Afatinib reverses EMT via inhibiting CD44-Stat3 axis to promote radiosensitivity in nasopharyngeal carcinoma10.3390/ph16010037 ↗
2. Dual regulation of sprouty 4 palmitoylation by ZDHHC7 and palmitoyl-protein thioesterase 1: a potential therapeutic strategy for cisplatin-resistant osteosarcoma10.34133/research.0708 ↗
3. Pancreatic cancer10.1016/S0140-6736(20)30974-0 ↗
4. Tumor microbiome diversity and composition influence pancreatic cancer outcomes10.1016/j.cell.2019.07.008 ↗
5. Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis
6. Clinical characteristics, treatment and outcome of pembrolizumab-induced acute pancreatitis10.1007/s10637-024-01452-0 ↗
7. Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy10.1038/s41565-019-0485-z ↗
8. Pancreatic cancer chemoresistance to gemcitabine10.3390/cancers9110157 ↗
9. Remotely triggerable drug delivery systems10.1002/adma.201002072 ↗
10. Recent advances in NIR-II fluorescence/photoacoustic dual-modality imaging probes, Coordin
11. Synergistic induction of immunogenic cell death by icaritin, JQ1, and doxorubicin to enhance immunotherapy in hepatocellular carcinoma10.1016/j.cej.2025.160987 ↗
12. The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives10.1016/j.addr.2022.114614 ↗
13. pH and glutathione dual-responsive dynamic cross-linked supramolecular network on mesoporous silica nanoparticles for controlled anticancer drug release10.1021/acsami.5b10534 ↗
14. Mesoporous silica nanoparticles in biomedical applications10.1039/c1cs15246g ↗
15. Synthesis of mesoporous silica nanoparticles10.1039/c3cs35405a ↗
16. Advances and opportunities of polydopamine coating in biosensing: preparation, functionality, and applications, Coordin
17. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
18. Folate-functionalized magnetic-mesoporous silica nanoparticles for drug/gene codelivery to potentiate the antitumor efficacy10.1021/acsami.6b02963 ↗
19. Polydopamine-based simple and versatile surface modification of polymeric nano drug carriers10.1021/nn405809c ↗
20. Blended nanoparticle system based on miscible structurally similar polymers: a safe, simple, targeted, and surprisingly high efficiency vehicle for cancer therapy10.1002/adhm.201400751 ↗
21. Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy10.1002/adhm.201300651 ↗
22. Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery10.1002/adhm.201200176 ↗
23. Targeted drug delivery via the folate receptor10.1016/S0169-409X(99)00062-9 ↗
24. The folate receptor as a rational therapeutic target for personalized cancer treatment10.1016/j.drup.2014.10.002 ↗
25. Advances in targeting the folate receptor in the treatment/imaging of cancers10.1039/C7SC04004K ↗
26. Exploiting the folate receptor α in oncology10.1038/s41571-020-0339-5 ↗
27. Drug resistance in cancer: an overview10.3390/cancers6031769 ↗
28. Metformin-induced stromal depletion to enhance the penetration of gemcitabine-loaded magnetic nanoparticles for pancreatic cancer targeted therapy10.1021/jacs.0c00650 ↗
29. Tumor microbiome links cellular programs and immunity in pancreatic cancer10.1016/j.ccell.2022.09.009 ↗
30. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine10.1126/science.aah5043 ↗
31. Cancer treatment: bacterial snack attack deactivates a drug10.1038/550337a ↗
32. The human tumor microbiome is composed of tumor type-specific intracellular bacteria10.1126/science.aay9189 ↗
33. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer10.1016/j.cell.2022.02.027 ↗
34. Dual-cascade responsive nanoparticles enhance pancreatic cancer therapy by eliminating tumor-resident intracellular bacteria10.1002/adma.202206765 ↗
35. Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia
36. Cascade-targeting poly(amino acid) nanoparticles eliminate intracellular bacteria via on-site antibiotic delivery10.1002/adma.202109789 ↗
37. Effective strategies for developing potent, broad-spectrum antibacterial and wound healing promotion from short-chain antimicrobial peptides10.1021/acsami.3c03069 ↗
38. Antibiotic-conjugated antimicrobial peptides for enhanced bacterial inhibition10.1039/D5RA02932E ↗
39. Antimicrobial peptides: structure, functions and translational applications10.1038/s41579-025-01200-y ↗
40. Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors10.1038/s41392-024-02028-3 ↗